| Net Cash Provided by (Used in) Operating Activities |
$453,155 |
USD |
-61% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$17,099,629 |
USD |
53% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$17,626,596 |
USD |
-51% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$73,812 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$313,922 |
USD |
93% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$313,922 |
USD |
93% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Interest Expense |
$100,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |